337 related articles for article (PubMed ID: 32866364)
21. Cytology-Ultrasonography Risk-Stratification Scoring System Based on Fine-Needle Aspiration Cytology and the Korean-Thyroid Imaging Reporting and Data System.
Hong MJ; Na DG; Baek JH; Sung JY; Kim JH
Thyroid; 2017 Jul; 27(7):953-959. PubMed ID: 28463597
[TBL] [Abstract][Full Text] [Related]
22. Incidental thyroid nodules and thyroid cancer: considerations before determining management.
Tufano RP; Noureldine SI; Angelos P
JAMA Otolaryngol Head Neck Surg; 2015 Jun; 141(6):566-72. PubMed ID: 25928353
[TBL] [Abstract][Full Text] [Related]
23. Molecular-derived estimation of risk of malignancy for indeterminate thyroid cytology diagnoses.
Ohori NP; Landau MS; Manroa P; Schoedel KE; Seethala RR
J Am Soc Cytopathol; 2020; 9(4):213-220. PubMed ID: 32336670
[TBL] [Abstract][Full Text] [Related]
24. The diagnostic accuracy of ultrasound-guided fine-needle aspiration biopsy for thyroid nodules three centimeters or larger in size.
Ucler R; Usluogulları CA; Tam AA; Ozdemir D; Balkan F; Yalcın S; Kıyak G; Ersoy PE; Guler G; Ersoy R; Cakır B
Diagn Cytopathol; 2015 Aug; 43(8):622-8. PubMed ID: 25914194
[TBL] [Abstract][Full Text] [Related]
25. Thyroid nodule molecular profiling: The clinical utility of Afirma Xpression Atlas for nodules with Afirma Genomic Sequencing Classifier-suspicious results.
Babazadeh NT; Sinclair TJ; Krishnamurthy V; Jin J; Heiden KB; Shin J; Berber E; Siperstein A
Surgery; 2022 Jan; 171(1):155-159. PubMed ID: 34924179
[TBL] [Abstract][Full Text] [Related]
26. American College of Radiology thyroid imaging report and data system combined with K-RAS mutation improves the management of cytologically indeterminate thyroid nodules.
Wu H; Zhang B; Cai G; Li J; Gu X
PLoS One; 2019; 14(7):e0219383. PubMed ID: 31295281
[TBL] [Abstract][Full Text] [Related]
27. Correlation Between Histological Diagnosis and Mutational Panel Testing of Thyroid Nodules: A Two-Year Institutional Experience.
Shrestha RT; Evasovich MR; Amin K; Radulescu A; Sanghvi TS; Nelson AC; Shahi M; Burmeister LA
Thyroid; 2016 Aug; 26(8):1068-76. PubMed ID: 27283257
[TBL] [Abstract][Full Text] [Related]
28. The diagnostic accuracy of ultrasound-guided fine-needle aspiration biopsy and the sonographic differences between benign and malignant thyroid nodules 3 cm or larger.
Yoon JH; Kwak JY; Moon HJ; Kim MJ; Kim EK
Thyroid; 2011 Sep; 21(9):993-1000. PubMed ID: 21834673
[TBL] [Abstract][Full Text] [Related]
29. Cytopathology-histopathology correlation and the effect of nodule diameter on diagnostic performance in patients undergoing thyroid fine-needle aspiration biopsy.
Yilmaz N; Cansu GB; Toru S; Sari R; Ocak GG; Arici C; Altunbas HA; Balci MK
J Cancer Res Ther; 2020 Dec; 16(Supplement):S53-S58. PubMed ID: 33380652
[TBL] [Abstract][Full Text] [Related]
30. Ultrasound and cytological characteristics of non-invasive follicular thyroid neoplasm with papillary-like nuclear features compared to papillary carcinomas.
Boursier L; Clerc Urmes I; Garon J; Klein M; Demarquet L
Ann Endocrinol (Paris); 2020 Feb; 81(1):28-33. PubMed ID: 32081363
[TBL] [Abstract][Full Text] [Related]
31. Bethesda classification is a valuable guide for fine needle aspiration reports and highly predictive especially for diagnosing aggressive variants of papillary thyroid carcinoma.
Evranos B; Polat SB; Baser H; Ozdemir D; Kilicarslan A; Yalcin A; Ersoy R; Cakir B
Cytopathology; 2017 Aug; 28(4):259-267. PubMed ID: 27666595
[TBL] [Abstract][Full Text] [Related]
32. Molecular fine-needle aspiration biopsy diagnosis of thyroid nodules by tumor specific mutations and gene expression patterns.
Eszlinger M; Paschke R
Mol Cell Endocrinol; 2010 Jun; 322(1-2):29-37. PubMed ID: 20083161
[TBL] [Abstract][Full Text] [Related]
33. Noninvasive Follicular Variant of Papillary Thyroid Carcinoma and the Afirma Gene-Expression Classifier.
Wong KS; Angell TE; Strickland KC; Alexander EK; Cibas ES; Krane JF; Barletta JA
Thyroid; 2016 Jul; 26(7):911-5. PubMed ID: 27219469
[TBL] [Abstract][Full Text] [Related]
34. Clinical impact of a cytological screening system using cyclin D1 immunostaining and genomic analysis for the diagnosis of thyroid nodules.
Teshima M; Tokita K; Ryo E; Matsumoto F; Kondo M; Ikegami Y; Shinomiya H; Otsuki N; Hiraoka N; Nibu KI; Yoshimoto S; Mori T
BMC Cancer; 2019 Mar; 19(1):245. PubMed ID: 30885146
[TBL] [Abstract][Full Text] [Related]
35. [Diagnostic value of BRAFV600E and RET/PTC oncogenes in thyroid nodule aspirates].
Guerra A; Carrano M; Angrisani E; Vitale M
Recenti Prog Med; 2013; 104(7-8):415-9. PubMed ID: 24042420
[TBL] [Abstract][Full Text] [Related]
36. Value of
Chen X; Zhou Q; Wang F; Zhang F; Du H; Zhang Q; Wu W; Gong X
AJNR Am J Neuroradiol; 2018 Dec; 39(12):2360-2365. PubMed ID: 30498021
[TBL] [Abstract][Full Text] [Related]
37. Getting more out of molecular testing for indeterminate thyroid nodules.
Angell TE
Cancer Cytopathol; 2019 Sep; 127(9):555-556. PubMed ID: 31237737
[No Abstract] [Full Text] [Related]
38. ADM3, TFF3 and LGALS3 are discriminative molecular markers in fine-needle aspiration biopsies of benign and malignant thyroid tumours.
Karger S; Krause K; Gutknecht M; Schierle K; Graf D; Steinert F; Dralle H; Führer D
Br J Cancer; 2012 Jan; 106(3):562-8. PubMed ID: 22223087
[TBL] [Abstract][Full Text] [Related]
39. Differences in Thyroid Nodule Cytology and Malignancy Risk Between Children and Adults.
Cherella CE; Angell TE; Richman DM; Frates MC; Benson CB; Moore FD; Barletta JA; Hollowell M; Smith JR; Alexander EK; Cibas ES; Wassner AJ
Thyroid; 2019 Aug; 29(8):1097-1104. PubMed ID: 31298618
[No Abstract] [Full Text] [Related]
40. Correlation of thyroid fine-needle aspiration with final histopathology: a case series.
Gürkan Dumlu E; Kiyak G; Bozkurt B; Tokaç M; Polat B; Cakir B; Güler G; Kiliç M
Minerva Chir; 2013 Apr; 68(2):191-7. PubMed ID: 23612233
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
